Pharmaceutical Executive May 17, 2022
Optimally designed SSO program can allow companies to deliver therapies to patients faster and at a more affordable cost.
Pharmaceutical leaders are at the center of extraordinary changes, with COVID-19 forcing them to re-evaluate their strategic roadmap and plans to remain competitive within the rapidly transforming industry. Expectations from patients, regulators, and the general public have increased significantly, due to the rapid development of the COVID vaccines. There is now a broader belief within the industry that it can be more agile than before in developing and delivering much-needed medicines safer and faster.
As industry leaders prepare their organizations for improved competitive positioning in the post-pandemic era, they are faced with several old and new challenges:1
- Rapidly changing consumer/patient...
Today's Sponsors
Today's Sponsor